Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

2.09
Delayed Data
As of 3:55pm ET
 +0.03 / +1.46%
Today’s Change
1.72
Today|||52-Week Range
3.22
0.00%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close2.06
Today’s open2.06
Day’s range2.05 - 2.09
Volume19,692
Average volume (3 months)31,102
Market cap$35.4M
Dividend yield--
Data as of 3:55pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)-4.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
OGENOragenics Inc+0.01+1.39%
CTRVContraVir Pharmaceut...+0.02+1.82%
PPHMPPeregrine Pharmaceut...-0.20-0.86%
VICLVical Inc-0.09-2.26%
Data as of 3:59pm ET, 08/29/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs